Abstract
Risk factors for pulmonary tuberculosis and pulmonary neoplastic process are interdependent. Antineoplastic treatment is a contributing factor in the reactivation of latent tuberculosis infection and the recurrence of pulmonary tuberculosis. The aim of the study was to evaluate the particularities of the evolution of patients with tuberculosis associated with pulmonary neoplastic process to identify recommendations for early detection of the neoplastic process. A retrospective, selective study was performed which included 105 patients distributed in the study group that included 50 cases with diagnosed pulmonary neoplatic process and the comparison group which consisted from 65 patients with pulmonary tuberculosis without current or previous neoplasia. Th e peculiarities of patients with associated neoplastic process was age over 55 years, urban residence, incomplete level of education, disadvantaged socio-economic peculiarities, immunosuppressive treatment (in one third of cases). Th e diagnosis of tuberculosis was established by the specialist, having a low rate of positive microbiological status and a wide range of clinical manifestations. Standardized antituberculosis treatment resulted in a low rate of therapeutic success. Conclusion: the standardized management of patients with pulmonary tuberculosis associated with the pulmonary neoplastic process led to the late detection of the neoplastic process and the completion of antituberculosis treatment with therapeutic success only in every second patient.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.